假包膜与ADC异质性在ccLS v2.0基础上对小肾肿块的附加诊断价值
该单中心回顾性研究纳入108个手术证实的≤4 cm小肾肿块,评估假包膜和归一化ADC标准差(nADCsd)在ccLS v2.0之外对透明细胞肾细胞癌(ccRCC)的独立预测价值。两位阅片者 multivariate 分析均显示两者为独立预测因子,加入ccLS后AUC显著提升,尤其在ccLS=3不确定亚组中假包膜出现率在ccRCC达90%-100%。
要点
- 假包膜和nADCsd是ccLS v2.0之外ccRCC的独立预测因子
- 加入假包膜和nADCsd后AUC从0.837/0.834提升至0.905/0.882
- ccLS=3不确定病灶中假包膜在ccRCC出现率90%-100%,非ccRCC仅22%-31%
局限性
- 单中心回顾性研究,结论尚待多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To identify which multiparametric MRI parameters provide independent diagnostic value for clear cell renal cell carcinoma (ccRCC) beyond the clear cell likelihood score (ccLS) version 2.0 in small renal masses (SRMs), and to determine whether their addition improves discriminative performance.
METHODS: This retrospective single-center study included patients with surgically confirmed SRMs (≤ 4 cm, > 25% enhancing component, no macroscopic fat) who underwent preoperative 1.5 T multiparametric MRI between September 2021 and May 2025. Two blinded radiologists of differing experience independently assigned ccLS v2.0 and evaluated qualitative and quantitative MR features. Univariate and multivariate logistic regression identified independent predictors; ROC analysis with the DeLong test assessed the added value of an augmented model over ccLS alone, with calibration and decision-curve analysis. Inter-reader agreement was quantified using Cohen's κ, quadratic-weighted κ, and the intraclass correlation.
RESULTS: Of 817 patients, 108 eligible SRMs (64 ccRCC) across 102 patients were analyzed. At a cutoff of ≥ 4, ccLS v2.0 yielded AUCs of 0.837 (Reader 1) and 0.834 (Reader 2). On multivariate analysis with ccLS entered as a covariate, pseudocapsule and normalized ADC standard deviation (nADCsd) were the independent predictors of ccRCC in both readers, with pseudocapsule the strongest binary predictor (OR 6.96, p = 0.003; OR 4.25, p = 0.015). Adding pseudocapsule and nADCsd to the ccLS score significantly improved discrimination (Reader 1: AUC 0.905 vs. 0.837, p = 0.032; Reader 2: 0.882 vs. 0.834, p = 0.048); after bootstrap optimism correction, the improvement persisted (corrected AUC 0.890 and 0.872), with favorable calibration and net benefit on decision-curve analysis. Within the indeterminate ccLS = 3 subgroup, pseudocapsule was present in 100% and 90% of ccRCC lesions versus 22% and 31% of non-ccRCC lesions, and nADCsd was the only quantitative feature significant in both readers. Pseudocapsule showed excellent inter-reader agreement (κ = 0.862) and nADCsd good agreement (ICC 0.755).
CONCLUSION: Pseudocapsule presence and nADCsd independently predicted ccRCC beyond ccLS v2.0 and provided significant added value, particularly in indeterminate ccLS = 3 lesions, pending multicenter validation.
引用
- Eryuruk U, Tasdemir MN, Pinar E, et al. Added diagnostic value of pseudocapsule and ADC heterogeneity beyond ccLS v2.0 in small renal masses. Abdom Radiol (NY). 2026. PMID: 42720763. doi:10.1007/s00261-026-05778-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。